JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Scope & Guideline

Illuminating the Dynamics of Life at the Molecular Level

Introduction

Immerse yourself in the scholarly insights of JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0739-1102
PublisherTAYLOR & FRANCIS INC
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Converge1981, from 1983 to 2024
AbbreviationJ BIOMOL STRUCT DYN / J. Biomol. Struct. Dyn.
Frequency18 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106

Aims and Scopes

The Journal of Biomolecular Structure & Dynamics focuses on the interactions and dynamics of biomolecules and their implications for biological processes and drug discovery. The journal emphasizes computational methods, experimental validation, and the integration of both approaches to explore molecular interactions and therapeutic potentials.
  1. Biomolecular Dynamics and Interactions:
    Research primarily revolves around the dynamic behavior and interactions of biomolecules, including proteins, nucleic acids, and small molecules, to understand their functional mechanisms.
  2. Computational Drug Discovery:
    The journal showcases innovative computational techniques for drug discovery, including molecular docking, molecular dynamics simulations, and virtual screening, to identify potential therapeutic agents.
  3. Natural Products and Phytochemicals:
    There is a strong emphasis on the exploration of natural products and phytochemicals as potential inhibitors or therapeutic agents against various diseases, particularly through computational methods.
  4. Multi-target Approaches:
    Research often involves multi-target strategies to enhance therapeutic efficacy, focusing on complex diseases like cancer and infectious diseases, utilizing systems biology and network pharmacology.
  5. Vaccine Development and Immunoinformatics:
    The journal includes studies on vaccine design and development using computational approaches, particularly in response to emerging viral infections like COVID-19.
Recent publications in the Journal of Biomolecular Structure & Dynamics indicate several emerging themes and trends that reflect the evolving landscape of biomolecular research. These trends highlight the journal's responsiveness to contemporary scientific challenges and its commitment to advancing knowledge in key areas.
  1. AI and Machine Learning in Drug Discovery:
    The integration of artificial intelligence and machine learning techniques in drug discovery is on the rise, showcasing a trend towards data-driven approaches that enhance predictive modeling and screening efficiency.
  2. COVID-19 Related Research:
    Research targeting SARS-CoV-2, including the development of vaccines and inhibitors, remains a significant focus, reflecting the ongoing global health impact of the pandemic.
  3. Systems Biology and Network Pharmacology:
    There is an increasing trend towards employing systems biology and network pharmacology approaches to understand complex interactions within biological systems and to identify novel therapeutic targets.
  4. Phytochemical Research and Natural Products:
    The exploration of phytochemicals and their potential therapeutic applications is gaining momentum, with more studies focusing on their molecular interactions and efficacy as drug candidates.
  5. Protein-Protein Interaction Studies:
    Research focusing on protein-protein interactions, particularly in the context of disease mechanisms and therapeutic targets, is emerging as a prominent theme, indicating a shift towards understanding molecular networks.

Declining or Waning

While the journal continues to thrive in many research areas, some themes have shown a decline in frequency or prominence in recent publications. This section outlines these waning scopes, indicating a shift in research focus.
  1. Traditional Medicinal Chemistry:
    There appears to be a waning interest in classical medicinal chemistry approaches focused solely on small molecule design, as the field increasingly shifts towards integrating computational and biological methods.
  2. Single Target Drug Discovery:
    The focus on single-target drug discovery is declining in favor of multi-target approaches that consider the complexity of biological systems and disease mechanisms.
  3. Experimental-Only Studies:
    Research papers that rely solely on experimental methods without computational backing are becoming less common, reflecting a trend towards more integrated methodologies.
  4. Basic Biochemical Studies:
    There is a noticeable decrease in the publication of basic biochemical studies that do not incorporate computational analysis, as the field evolves to prioritize interdisciplinary approaches.

Similar Journals

JOURNAL OF BIOMOLECULAR NMR

Unraveling the complexities of biomolecules.
Publisher: SPRINGERISSN: 0925-2738Frequency: 12 issues/year

JOURNAL OF BIOMOLECULAR NMR, published by SPRINGER, is a leading academic journal dedicated to advancing the field of molecular spectroscopy, particularly in the realm of biomolecular studies. With an ISSN of 0925-2738 and an E-ISSN of 1573-5001, the journal has been consistently publishing high-quality research since its inception in 1991, and continues to do so through 2024. The journal maintains an impressive reputation within its category, achieving a Q2 ranking in Biochemistry and a Q1 ranking in Spectroscopy as of 2023, reflecting its commitment to excellence and innovation in scientific research. Notably, it ranks 26th in Scopus for Chemistry - Spectroscopy and 198th for Biochemistry, indicating its significance in the scholarly community. Although it operates under a traditional access model, the journal serves as an essential resource for researchers, professionals, and students interested in the molecular nuances of biomolecules, offering insights that drive advances in biochemistry and related disciplines.

STRUCTURE

Unveiling the intricate dance of proteins and structures.
Publisher: CELL PRESSISSN: 0969-2126Frequency: 12 issues/year

STRUCTURE is a premier academic journal published by CELL PRESS, dedicated to advancing the field of structural biology and molecular biology since its inception in 1993. With an impressive reputation, it is recognized as a Q1 journal in both Molecular Biology and Structural Biology categories, reflecting its high impact within the academic community. The journal holds a significant position in Scopus rankings, placing 10th among 49 in Structural Biology and 100th among 410 in Molecular Biology, marking it as a key resource with a strong influence on ongoing research. Researchers and professionals alike will find STRUCTURE an invaluable platform for disseminating cutting-edge findings related to protein structure, dynamics, and interactions, fostering insights that can lead to groundbreaking applications in medicine and biotechnology. Although the journal follows a traditional subscription model, it continues to attract a diverse array of submissions, ensuring a vibrant exchange of knowledge in the ever-evolving landscape of structural and molecular biology. Access to its content can enhance the understanding of intricate biological mechanisms, making it essential reading for experts, students, and anyone passionate about the molecular underpinnings of life.

Doklady Biochemistry and Biophysics

Advancing the Frontiers of Biochemical and Biophysical Research
Publisher: MAIK NAUKA/INTERPERIODICA/SPRINGERISSN: 1607-6729Frequency: 6 issues/year

Doklady Biochemistry and Biophysics is a vital resource for the advancement of knowledge in the fields of biochemistry and biophysics, published by MAIK NAUKA/INTERPERIODICA/SPRINGER. Featuring an ISSN of 1607-6729 and an E-ISSN of 1608-3091, this journal plays a critical role in disseminating research findings and fostering scholarly discourse. Despite its recent ranking in the Q4 quartile for biochemistry and biophysics in 2023, it serves as an essential platform for researchers exploring these intertwined disciplines. The journal’s scope encompasses a wide variety of topics, enhancing the understanding of biochemical processes and physical principles in biological systems. With converged years of publication from 2001 to 2024, it stands as a continual source of knowledge for its readers, who include researchers, professionals, and students alike. While the journal currently does not offer open access options, its contributions remain significant within the scholarly community, illustrated by its competitive Scopus rankings across related fields.

Current Computer-Aided Drug Design

Exploring New Horizons in Drug Design and Molecular Medicine
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-4099Frequency: 4 issues/year

Current Computer-Aided Drug Design, published by BENTHAM SCIENCE PUBL LTD, is a pivotal journal dedicated to the integration of computer-aided methodologies within the drug design process. With its ISSN 1573-4099 and E-ISSN 1875-6697, this journal serves as a vital resource for researchers, professionals, and students interested in advancing the fields of pharmacology and molecular medicine. Operating under a framework that spans from 2006 to 2024, it aims to foster innovative approaches and discussions surrounding drug design strategies, computational techniques, and the therapeutic potential of novel compounds. Although it currently holds a Q4 rating in Drug Discovery and Molecular Medicine as well as a Q3 in Medicine (miscellaneous) within the 2023 category quartiles, the journal continues to enhance its visibility and relevance in the academic community. Its Scopus rankings reflect its commitment to quality research, positioning it in the context of drug discovery and molecular studies. As the field of drug design evolves, Current Computer-Aided Drug Design remains an essential platform for disseminating cutting-edge findings and facilitating collaboration among specialists aiming for significant advancements in drug development.

JOURNAL OF MOLECULAR RECOGNITION

Pioneering Research in Biochemical Interactions
Publisher: WILEYISSN: 0952-3499Frequency: 12 issues/year

JOURNAL OF MOLECULAR RECOGNITION, published by Wiley, is an esteemed academic journal that has been at the forefront of molecular biology and structural biology research since its inception in 1988. With its ISSN 0952-3499 and E-ISSN 1099-1352, this journal serves as a vital platform for disseminating innovative studies and findings in the realms of biochemical interactions and molecular structure elucidation. Although currently positioned in Quartile 4 of both molecular and structural biology categories based on 2023 metrics, the journal is dedicated to advancing knowledge in quantitative and qualitative molecular recognition processes. Researchers, professionals, and students alike will find that this journal is instrumental in keeping abreast of cutting-edge developments in the field, even as it continues to build its impact and reputation within the dynamic research landscape. Located in the United Kingdom, it is committed to promoting a diverse range of studies that drive forward the understanding of molecular interaction phenomena, thus empowering its readership to contribute effectively to the field.

BIOPHYSICAL CHEMISTRY

Connecting disciplines to illuminate the science of life.
Publisher: ELSEVIERISSN: 0301-4622Frequency: 12 issues/year

BIOPHYSICAL CHEMISTRY, published by Elsevier, is a prestigious journal with a long-standing tradition since its inception in 1973. This highly respected journal focuses on the intersections of biochemistry, biophysics, and organic chemistry, providing a critical platform for researchers, professionals, and students to disseminate pivotal findings in these dynamic fields. With an impressive impact factor that reflects its robust academic influence and high citation rates, it ranks within the Q2 quartile among its peers in multiple categories, indicating its significance in the scholarly community. The journal, hosted in the Netherlands, encompasses a diverse range of topics, from molecular interactions to protein folding, and serves as an essential resource for those engaged in cutting-edge research. Researchers looking to share their work with a global audience will find BIOPHYSICAL CHEMISTRY an invaluable outlet, fostering the advancement of knowledge in this crucial area of science. For more information, visit the journal's page on the Elsevier platform.

AIMS Molecular Science

Advancing Molecular Discoveries for a Global Audience
Publisher: AMER INST MATHEMATICAL SCIENCES-AIMSISSN: 2372-0301Frequency: 4 issues/year

AIMS Molecular Science is a premier open-access journal published by the American Institute of Mathematical Sciences (AIMS), dedicated to the advancement and dissemination of high-quality research in the field of molecular science. Since its inception in 2014, this journal has established itself as a vital platform for researchers and professionals aiming to share their findings in molecular biology, chemistry, and interdisciplinary studies related to these domains. With an increasing focus on the accessibility of scientific knowledge, AIMS Molecular Science supports the open-access movement, ensuring that all published articles are freely available to the global research community. The journal emphasizes originality and significance in research, promoting innovative scientific methodologies and applications. By fostering collaboration and dialogue among scientists, AIMS Molecular Science plays a crucial role in advancing understanding and stimulating progress in molecular sciences.

Biomolecules

Advancing biochemical discovery, one molecule at a time.
Publisher: MDPIISSN: Frequency: 12 issues/year

Biomolecules is a prestigious, peer-reviewed journal published by MDPI that has been dedicated to advancing the field of biochemical research since its launch in 2011. With an impressive impact factor positioning it in Q1 for Biochemistry and Q2 for Molecular Biology as of 2023, this journal serves as a vital platform for disseminating high-quality research findings related to biological macromolecules, including proteins, nucleic acids, and carbohydrates. Operating as an Open Access journal, it ensures that vital research is accessible to all, furthering knowledge dissemination and collaboration within the scientific community. Located in Basel, Switzerland, the journal has established a significant presence in major academic databases, holding commendable Scopus rankings in both Biochemistry and Molecular Biology. Researchers, professionals, and students will find Biomolecules an invaluable resource for cutting-edge research, reviews, and insights in the rapidly evolving domains of biochemistry and molecular biology.

BioImpacts

Catalyzing innovative research for a healthier future.
Publisher: TABRIZ UNIV MEDICAL SCIENCES & HEALTH SERVICESISSN: 2228-5652Frequency: 4 issues/year

BioImpacts, an esteemed journal published by Tabriz University of Medical Sciences & Health Services, is a prominent platform dedicated to advancing the fields of Biochemistry, Genetics, Molecular Biology, Medicine, and Pharmaceutical Science. Established in 2011, this Open Access journal ensures that vital research findings are freely accessible to the global academic community. With an impressive presence in the Scopus database, BioImpacts currently holds a Q2 quartile ranking in its respective categories, reflecting its contribution to scientific discourse and its importance as a critical resource for researchers and practitioners alike. The journal's dynamic scope encompasses a wide range of topics, highlighting innovative research that addresses contemporary challenges in health and disease. Operating out of Tabriz, Iran, BioImpacts is committed to fostering interdisciplinary collaboration and knowledge dissemination through their dedicated publication efforts, which span from 2011 to 2024. Researchers, professionals, and students are encouraged to explore the rich content and cutting-edge studies presented in this journal, making it an indispensable resource in the scientific community.

INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS

Connecting scholars through groundbreaking discoveries.
Publisher: NATL INST SCIENCE COMMUNICATION-NISCAIRISSN: 0301-1208Frequency: 6 issues/year

INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS is a well-regarded academic journal that serves as a vital platform for researchers in the fields of biochemistry and biophysics. Published by the NATL INST SCIENCE COMMUNICATION-NISCAIR since its inception in 1972, this Open Access journal has committed itself to disseminating high-quality research and advancements in these dynamic fields, allowing readers worldwide to access vital findings since 2009. The journal maintains a robust presence in the academic landscape, achieving noteworthy rankings in 2023, placing it in the Q4 category for Biochemistry and Q3 for both Biophysics and miscellaneous Medicine, alongside its respectable Scopus rankings. With an emphasis on original research articles, reviews, and educational contributions, the INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS plays an essential role in fostering scientific dialogue and collaboration among professionals and students alike. For scholars seeking to stay at the forefront of biochemistry and biophysics research, this journal is an indispensable resource that fosters knowledge exchange and elevates the field on both a national and international scale.